From the Department of Medicine, Stanford University School of Medicine, and the Stanford Cancer Center, Palo Alto (L.G.), and the University of California, San Francisco, San Francisco (R.K.K.) — both in California; the Mass General Cancer Center, Harvard Medical School (L.G.), and Dana–Farber Cancer Institute (T.A.A.) — both in Boston; the University of Texas M.D. Anderson Cancer Center, Houston (F.M.-B.); the Drug Development Department, Gustave Roussy, Villejuif (A.H.), and Centre Léon Bérard,... (2023-01-19時点)
